Analyst Coverage

Aimmune Therapeutics is covered by the following analysts:
Firm Analyst
Cantor Fitzgerald
Charles Duncan Ph.D.
Boris Peaker, Ph.D.
Credit Suisse
Evan Seigerman
Goldman Sachs
Paul Choi
H.C. Wainwright
Andrew S. Fein
JMP Securities
Liisa Bayko
Piper Jaffray
Christopher Raymond
RBC Capital Markets, LLC
Kennen MacKay, Ph.D.
Robert W. Baird & Co.
Brian Skorney, CFA
Roth Capital Partners, LLC
Zegbeh Jallah, Ph.D.
Derek Archila
Wedbush Securities
Liana Moussatos, Ph.D.
Any opinions, estimates or forecasts regarding Aimmune’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Aimmune or its leadership team. Aimmune does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.